DiaMedica Therapeutics, Inc.

  • Home
  • Our Focus
    • Overview
    • Literature & Publications
  • Pipeline
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • Clinical Trials
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • ReMEDy2 Trial
    • Overview
    • About ReMEDy2
    • Stroke Disease
    • For Physicians
    • Trial Locations
  • About DiaMedica
    • Overview
    • Leadership
    • Careers
    • Contact
  • Investors Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Data
    • Analyst Coverage
    • Financial Reports & SEC Filings
    • Governance
    • Resources

Press Releases

Investors Relations

Investors Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Data
    • Nasdaq Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • Financial Reports & SEC Filings
    • SEC Filings
    • Annual Reports
    • Tax Information (PFIC)
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • Investor Contact
    • FAQ
    • Share Consolidation Instructions
    • Email Alerts
Mar 10, 2021 4:04pm EST

DiaMedica Therapeutics Announces 2020 Financial Results and Provides a Business Update

Mar 10, 2021 8:52am EST

DiaMedica Therapeutics to Present Research at International Stroke Virtual Conference

Mar 09, 2021 4:04pm EST

DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke

Mar 08, 2021 5:44pm EST

DiaMedica Therapeutics to Participate at Upcoming Investor Conferences

Mar 03, 2021 4:04pm EST

DiaMedica Therapeutics to Report Fourth Quarter 2020 Financials and Provide a Business Update March 11, 2021

Feb 25, 2021 8:48am EST

DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting

Jan 11, 2021 8:00am EST

DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect Conference

Dec 15, 2020 8:04am EST

DiaMedica Therapeutics Announces Enrollment of Last Patient in Diabetic Kidney Disease Cohort of Phase 2 REDUX CKD Study

Dec 10, 2020 8:03am EST

DiaMedica Therapeutics Announces Successful Type B Meeting with FDA for the Study of DM199 in Patients with Acute Ischemic Stroke

Nov 19, 2020 9:04am EST

DiaMedica Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

  • Previous
  • 1…
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …16
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2025 DiaMedica Therapeutics, Inc. All Rights Reserved.
Twitter LinkedIn
Privacy Policy Disclaimer Sitemap